Cold Chain Focus RUSSIA


With the Russian pharma market expected to be worth $37.15bn in 2016 and a raft of legislative changes focused on increasing the number of locally produced pharma products, the region is a key area of focus for many international and pharma and bio companies looking to expand their market and operations.

Learn more about Cold Supply Chain in Russia in this resource centre